A detailed history of Beaumont Financial Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 146,507 shares of JNJ stock, worth $22.7 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares
146,507
Previous 148,416 1.29%
Holding current value
$22.7 Million
Previous $26.3 Million 9.16%
% of portfolio
2.3%
Previous 2.37%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $307,978 - $342,703
-1,909 Reduced 1.29%
146,507 $23.9 Million
Q2 2022

Aug 04, 2022

SELL
$168.19 - $186.01 $1.47 Million - $1.62 Million
-8,735 Reduced 5.56%
148,416 $26.3 Million
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $222,977 - $253,221
1,410 Added 0.91%
157,151 $27.9 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $378,753 - $420,241
2,429 Added 1.58%
155,741 $26.6 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $239,181 - $265,795
-1,481 Reduced 0.96%
153,312 $24.8 Million
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $385,303 - $413,305
2,416 Added 1.59%
154,793 $25.5 Million
Q1 2021

May 04, 2021

BUY
$153.07 - $170.48 $324,508 - $361,417
2,120 Added 1.41%
152,377 $25 Million
Q4 2020

Feb 08, 2021

SELL
$137.11 - $157.38 $2.06 Million - $2.36 Million
-15,000 Reduced 9.08%
150,257 $23.6 Million
Q3 2020

Nov 02, 2020

SELL
$140.38 - $153.83 $192,882 - $211,362
-1,374 Reduced 0.82%
165,257 $24.6 Million
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $597,807 - $721,721
-4,641 Reduced 2.71%
166,631 $23.4 Million
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $154,706 - $214,354
1,392 Added 0.82%
171,272 $22.5 Million
Q4 2019

Feb 06, 2020

SELL
$127.5 - $146.44 $228,735 - $262,713
-1,794 Reduced 1.05%
169,880 $24.8 Million
Q3 2019

Nov 06, 2019

BUY
$126.95 - $142.14 $20,565 - $23,026
162 Added 0.09%
171,674 $22.2 Million
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $225,840 - $248,381
1,722 Added 1.01%
171,512 $23.9 Million
Q1 2019

May 06, 2019

BUY
$125.72 - $139.79 $550,905 - $612,559
4,382 Added 2.65%
169,790 $23.7 Million
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $105,028 - $126,403
-855 Reduced 0.51%
165,408 $21.3 Million
Q3 2018

Nov 02, 2018

BUY
$121.58 - $142.88 $703,705 - $826,989
5,788 Added 3.61%
166,263 $23 Million
Q2 2018

Aug 06, 2018

BUY
$119.4 - $131.76 $847,620 - $935,364
7,099 Added 4.63%
160,475 $19.5 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $263,835 - $312,427
2,109 Added 1.39%
153,376 $19.7 Million
Q4 2017

Feb 05, 2018

BUY
$131.22 - $143.62 $79,781 - $87,320
608 Added 0.4%
151,267 $21.1 Million
Q3 2017

Oct 31, 2017

SELL
$129.47 - $135.38 $350,863 - $366,879
-2,710 Reduced 1.77%
150,659 $19.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
153,369
153,369 $20.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Beaumont Financial Partners, LLC Portfolio

Follow Beaumont Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.